CHESTER, N.J., Aug. 1 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. is scheduled to announce its sales and earnings results for the fourth quarter and fiscal year 2006 on Thursday, Aug. 24, 2006, before the market opens. At 9:00 a.m. (EDT) on that day, Adams will conduct a conference call to review the financial results and highlights of the quarter. Michael J. Valentino, president and CEO, and David P. Becker, executive vice president, CFO and treasurer, will host the conference call.
To listen live to the call, dial 1-877-669-8882 or 1-706-758-9391. A replay of the call will be available starting at approximately 12 p.m. on Aug. 24 through 5 p.m. on Aug. 31. To listen to the replay, dial 1-800-642-1687 or 1-706-645-9291 and enter the conference ID# 3548505.
A live audio webcast of the conference call also will be available by going to the Calendar of Events section of Adams’ Investor Relations web site, http://investor.adamsrt.com. A replay of the webcast will be available starting at approximately 11 a.m. on Aug. 24 through 5 p.m. on Sept. 24.
About Adams Respiratory Therapeutics, Inc.
Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.
Adams Respiratory Therapeutics, Inc.
CONTACT: Investor/Media Contact - Janet M. Barth, +1-908-879-2428
